Terms: = Sarcomas AND TOP2A, TOP2, TP2A
24 results:
1. Exploration of s new biomarker in osteosarcoma and association with clinical outcomes:
Xu Y; Chen P; Liu D; Xu Q; Meng H; Wang X
J Gene Med; 2023 Nov; 25(11):e3528. PubMed ID: 37246449
[TBL] [Abstract] [Full Text] [Related]
2. Pharmacogenetics of the Primary and Metastatic Osteosarcoma: Gene Expression Profile Associated with Outcome.
Trujillo-Paolillo A; Tesser-Gamba F; Seixas Alves MT; Filho RJG; Oliveira R; Petrilli AS; Toledo SRC
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982681
[TBL] [Abstract] [Full Text] [Related]
3. Identification and validation of eight estrogen-related genes for predicting prognosis of papillary thyroid cancer.
Zeng Y; Ma W; Li L; Zhuang G; Luo G; Zhou H; Hao W; Liu Y; Guo F; Tian M; Ruan X; Gao M; Zheng X
Aging (Albany NY); 2023 Mar; 15(5):1668-1684. PubMed ID: 36917092
[TBL] [Abstract] [Full Text] [Related]
4. Loss of RanGAP1 drives chromosome instability and rapid tumorigenesis of osteosarcoma.
Gong Y; Zou S; Deng D; Wang L; Hu H; Qiu Z; Wei T; Yang P; Zhou J; Zhang Y; Zhu W; Xie X; Liao Z; Yang J; Zhang S; Liu A; Jiang Y; Zou Z; Bai X
Dev Cell; 2023 Feb; 58(3):192-210.e11. PubMed ID: 36696903
[TBL] [Abstract] [Full Text] [Related]
5. top2a Expression in Pheochromocytoma and Abdominal Paraganglioma: a Marker of Poor Clinical Outcome?
Solhusløkk Höse K; Stenman A; Svahn F; Larsson C; Juhlin CC
Endocr Pathol; 2023 Mar; 34(1):129-141. PubMed ID: 36656469
[TBL] [Abstract] [Full Text] [Related]
6. In vitro anti-synovial sarcoma effect of diallyl trisulfide and mRNA profiling.
Xia SL; Ma ZY; Wang B; Gao F; Yi CG; Zhou XX; Guo SY; Zhou L
Gene; 2022 Mar; 816():146172. PubMed ID: 34995734
[TBL] [Abstract] [Full Text] [Related]
7. Long non‑coding RNA‑DUXAP8 regulates top2a in the growth and metastasis of osteosarcoma via microRNA‑635.
Yang T; Guo JP; Li F; Xiu C; Wang H; Duan XL
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33982765
[TBL] [Abstract] [Full Text] [Related]
8. Molecular differential analysis of uterine leiomyomas and leiomyosarcomas through weighted gene network and pathway tracing approaches.
Sahly NN; Banaganapalli B; Sahly AN; Aligiraigri AH; Nasser KK; Shinawi T; Mohammed A; Alamri AS; Bondagji N; Elango R; Shaik NA
Syst Biol Reprod Med; 2021 Jun; 67(3):209-220. PubMed ID: 33685300
[TBL] [Abstract] [Full Text] [Related]
9. Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma.
Godel M; Morena D; Ananthanarayanan P; Buondonno I; Ferrero G; Hattinger CM; Di Nicolantonio F; Serra M; Taulli R; Cordero F; Riganti C; Kopecka J
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599901
[TBL] [Abstract] [Full Text] [Related]
10. Molecular variations in uterine carcinosarcomas identify therapeutic opportunities.
Crane E; Naumann W; Tait D; Higgins R; Herzog T; Brown J
Int J Gynecol Cancer; 2020 Apr; 30(4):480-484. PubMed ID: 32114514
[TBL] [Abstract] [Full Text] [Related]
11. Identification of a novel diagnostic gene expression signature to discriminate uterine leiomyoma from leiomyosarcoma.
Adams CL; Dimitrova I; Post MD; Gibson L; Spillman MA; Behbakht K; Bradford AP
Exp Mol Pathol; 2019 Oct; 110():104284. PubMed ID: 31301306
[TBL] [Abstract] [Full Text] [Related]
12. Expression and inhibition of BRD4, EZH2 and top2a in neurofibromas and malignant peripheral nerve sheath tumors.
Amirnasr A; Verdijk RM; van Kuijk PF; Taal W; Sleijfer S; Wiemer EAC
PLoS One; 2017; 12(8):e0183155. PubMed ID: 28813519
[TBL] [Abstract] [Full Text] [Related]
13. Vulvar and vaginal melanoma: A unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma.
Hou JY; Baptiste C; Hombalegowda RB; Tergas AI; Feldman R; Jones NL; Chatterjee-Paer S; Bus-Kwolfski A; Wright JD; Burke WM
Cancer; 2017 Apr; 123(8):1333-1344. PubMed ID: 28026870
[TBL] [Abstract] [Full Text] [Related]
14. Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone.
Damiani RM; Moura DJ; Viau CM; Caceres RA; Henriques JAP; Saffi J
Arch Toxicol; 2016 Sep; 90(9):2063-2076. PubMed ID: 27342245
[TBL] [Abstract] [Full Text] [Related]
15. top2a copy number and top2a expression in uterine benign smooth muscle tumours and leiomyosarcoma.
Baiocchi G; Poliseli FL; De Brot L; Mantoan H; Schiavon BN; Faloppa CC; Vassallo J; Soares FA; Cunha IW
J Clin Pathol; 2016 Oct; 69(10):884-9. PubMed ID: 26994023
[TBL] [Abstract] [Full Text] [Related]
16. The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells.
Deng S; Yan T; Nikolova T; Fuhrmann D; Nemecek A; Gödtel-Armbrust U; Kaina B; Wojnowski L
Br J Pharmacol; 2015 May; 172(9):2246-57. PubMed ID: 25521189
[TBL] [Abstract] [Full Text] [Related]
17. Extraskeletal myxoid chondrosarcoma of the vulva with PLAG1 gene activation: molecular genetic characterization of 2 cases.
Dotlic S; Gatalica Z; Wen W; Ghazalpour A; Mangham C; Babic D; Zekan J; Vranic S
Appl Immunohistochem Mol Morphol; 2014 Aug; 22(7):537-42. PubMed ID: 24185117
[TBL] [Abstract] [Full Text] [Related]
18. Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.
Peacock JD; Cherba D; Kampfschulte K; Smith MK; Monks NR; Webb CP; Steensma M
J Transl Med; 2013 Sep; 11():213. PubMed ID: 24040940
[TBL] [Abstract] [Full Text] [Related]
19. Sensitivity to top2 targeting chemotherapeutics is regulated by Oct1 and FILIP1L.
Lu H; Hallstrom TC
PLoS One; 2012; 7(8):e42921. PubMed ID: 22900064
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic value of proliferation in pleomorphic soft tissue sarcomas: a new look at an old measure.
Seinen JM; Jönsson M; Bendahl PO; Baldetorp B; Rambech E; Åkerman M; Rydholm A; Nilbert M; Carneiro A
Hum Pathol; 2012 Dec; 43(12):2247-54. PubMed ID: 22789784
[TBL] [Abstract] [Full Text] [Related]
[Next]
